Average Co-Inventor Count = 4.26
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ribozyme Pharmaceuticals, Incorporated (24 from 110 patents)
2. Sirna Therapeutics, Inc. (4 from 138 patents)
3. University of Montreal (3 from 7 patents)
4. Massachusetts Institute of Technology (2 from 8,375 patents)
5. Other (1 from 832,891 patents)
6. The UAB Research Foundation (The University of Alabama at Birmingham) (1 from 647 patents)
7. Ribozyme Pharmacueticals, Inc. (1 from 1 patent)
32 patents:
1. 8846894 - RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
2. 7074601 - Nucleozymes
3. 7041817 - Synthesis, deprotection, analysis and purification of RNA and ribozymes
4. 6849726 - Non-nucleotide containing RNA
5. 6713456 - Nucleozymes
6. 6649751 - Synthesis, deprotection, analysis and purification of RNA and ribozymes
7. 6586238 - Enzymatic nucleic acids containing 5′-and or 3′-cap structures
8. 6555668 - Non-nucleotide containing enzymatic nucleic acid
9. 6528639 - Base-modified enzymatic nucleic acid
10. 6469158 - Synthesis, deprotection, analysis and purification of RNA and ribozymes
11. 6437117 - Synthesis, deprotection, analysis and purification for RNA and ribozymes
12. 6365374 - 2′-deoxy-2′-alkylnucleotide containing nucleic acid
13. 6362323 - Non-nucleotide containing nucleic acid
14. 6353098 - Synthesis, deprotection, analysis and purification of RNA and ribozymes
15. 6159714 - Catalytic DNA